Drugs · acquisition-cost intelligence
DermacinRx PHN Pak
lidocaine· ingredient lidocaineAmides· LIDOCAINE 50 mg/1; LIDOCAINE 50 mg/g; LIDOCAINE 700 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.95
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$1.92 |
| ALCEMISTE | $0.05101 | −$1.89 |
| Lidocaine Viscous | $0.07984 | −$1.87 |
| Lidocaine | $0.09024 | −$1.85 |
| lidocaine | $0.15755 | −$1.79 |
| Cadira Compliant Blood Stat | $0.21848 | −$1.73 |
| LIDOCAINE HCl | $0.24343 | −$1.70 |
| Lidocaine | $0.35160 | −$1.59 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 4
Prior auth 94% · Step therapy 0% · Quantity limit 91% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.